ES2107522T3 - 2-descarboxil-2-aminoalquil-prostaglandinas como agentes hipotensivos oculares. - Google Patents

2-descarboxil-2-aminoalquil-prostaglandinas como agentes hipotensivos oculares.

Info

Publication number
ES2107522T3
ES2107522T3 ES92900219T ES92900219T ES2107522T3 ES 2107522 T3 ES2107522 T3 ES 2107522T3 ES 92900219 T ES92900219 T ES 92900219T ES 92900219 T ES92900219 T ES 92900219T ES 2107522 T3 ES2107522 T3 ES 2107522T3
Authority
ES
Spain
Prior art keywords
hypotensive
prostaglandinas
descarboxil
aminoalquil
eye agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900219T
Other languages
English (en)
Inventor
Ming Fai Chan
David Frederick Woodward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ES2107522T3 publication Critical patent/ES2107522T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Feedback Control In General (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DE 2-DECARBOXIL-2AMINOALQUIL DE PROSTAGLANDINAS QUE SE PRODUCEN DE FORMA NATURAL O DE MANERA SINTETICA, A DERIVADOS N-SUSTITUIDOS, PRODROGAS DE ESTERES Y HOMOLOGOS DE TALES COMPUESTOS QUE SON POTENTES HIPOTENSORES OCULARES, Y SON PARTICULARMENTE ADECUADOS PARA EL TRATAMIENTO DEL GLAUCOMA.
ES92900219T 1990-11-09 1991-10-30 2-descarboxil-2-aminoalquil-prostaglandinas como agentes hipotensivos oculares. Expired - Lifetime ES2107522T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/611,029 US5270049A (en) 1990-11-09 1990-11-09 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives

Publications (1)

Publication Number Publication Date
ES2107522T3 true ES2107522T3 (es) 1997-12-01

Family

ID=24447325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900219T Expired - Lifetime ES2107522T3 (es) 1990-11-09 1991-10-30 2-descarboxil-2-aminoalquil-prostaglandinas como agentes hipotensivos oculares.

Country Status (15)

Country Link
US (1) US5270049A (es)
EP (1) EP0556296B1 (es)
JP (1) JP3488456B2 (es)
AT (1) ATE158506T1 (es)
AU (1) AU656752B2 (es)
BR (1) BR9107071A (es)
CA (1) CA2095430A1 (es)
DE (1) DE69127755T2 (es)
ES (1) ES2107522T3 (es)
HU (1) HUT70500A (es)
IE (1) IE913906A1 (es)
IL (1) IL99975A (es)
NZ (1) NZ240502A (es)
WO (1) WO1992008465A2 (es)
ZA (1) ZA918869B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288754A (en) * 1992-02-04 1994-02-22 Allergan, Inc. Polar C-1 esters of prostaglandins
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
US6124353A (en) * 1992-11-12 2000-09-26 Allergan Sales, Inc. Method of treating ocular hypertension with 8-epi prostaglandins
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
WO1998021180A1 (en) 1995-06-07 1998-05-22 Alcon Laboratories, Inc. Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
US6066671A (en) 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US6096783A (en) * 1998-12-15 2000-08-01 Alcon Laboratories, Inc. Cyclobutane prostaglandin analogues as ocular hypotensive agents
US6160013A (en) * 1998-12-17 2000-12-12 Alcon Laboratories, Inc. 14-aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6211226B1 (en) 1998-12-17 2001-04-03 Alcon Laboratories, Inc. 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122282A (en) * 1975-12-29 1978-10-24 The Upjohn Company 2-Decarboxy-2-carboxyamino-methyl-PGFα compounds
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPH0643313B2 (ja) * 1986-03-13 1994-06-08 ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク 緑内障の局所治療用組成物
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
EP0455264B1 (en) * 1987-09-18 1994-07-13 R-Tech Ueno Ltd. Ocular hypotensive agents
US4927846A (en) * 1988-11-23 1990-05-22 Allergan, Inc. Intraocular pressure reducing 1,11-lactone prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5011856A (en) * 1990-03-12 1991-04-30 Allergan, Inc. Use of prostaglandin F3 α as an ocular hypotensive agent
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives

Also Published As

Publication number Publication date
US5270049A (en) 1993-12-14
DE69127755T2 (de) 1998-04-30
DE69127755D1 (de) 1997-10-30
IE913906A1 (en) 1992-05-20
EP0556296B1 (en) 1997-09-24
ATE158506T1 (de) 1997-10-15
CA2095430A1 (en) 1992-05-10
WO1992008465A3 (en) 1992-10-15
JP3488456B2 (ja) 2004-01-19
WO1992008465A2 (en) 1992-05-29
HU9301327D0 (en) 1993-09-28
AU9041491A (en) 1992-06-11
AU656752B2 (en) 1995-02-16
NZ240502A (en) 1995-07-26
IL99975A (en) 1996-05-14
BR9107071A (pt) 1993-09-21
IL99975A0 (en) 1992-08-18
EP0556296A1 (en) 1993-08-25
ZA918869B (en) 1992-07-29
HUT70500A (en) 1995-10-30
JPH06501482A (ja) 1994-02-17

Similar Documents

Publication Publication Date Title
ES2107522T3 (es) 2-descarboxil-2-aminoalquil-prostaglandinas como agentes hipotensivos oculares.
ES2074736T3 (es) Procedimiento para la produccion de polifluoroolefinas.
ES2168357T3 (es) Agonistas del receptor ep2 como agentes para disminuir la presion intraocular.
ES2186670T3 (es) Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular.
ES2183473T3 (es) Derivados de acido piridonacarboxilico como agentes antibacterianos.
AR038428A2 (es) Compuestos fluorados de marcfortina
DE69229232D1 (de) Kollagenprodukte
ES2133720T3 (es) Acidos ciclopentan(en)heptenoicos o heptanoicos y derivados de los mismos utiles como agentes terapeuticos.
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
DE69800726T2 (de) Hüftgurtel für Strumpfhosen
DE69311361D1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
MX9302906A (es) Derivados de mercaptoacetilamida novedosos utiles como inhibidores de la encefalinasa.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
CO4700426A1 (es) Ligandos especificos del neuropeptido y1
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
AR003073A1 (es) Empleo de amidas del acido poliasparaginico a modo de agentes auxiliares para el cuerpo y cueros tratados con dichos compuestos.
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES2194092T3 (es) Composiciones de lavado blanqueantes.
ES2100689T3 (es) Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2.
MX9205358A (es) Compuestos para tratar enfermedades relacionadas con leucotrieno.
ES2062202T3 (es) Derivado del indol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 556296

Country of ref document: ES